Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px
Organisation › Details

Ysios Capital (Group)

Ysios Capital is an independent venture capital firm providing private equity financing to early through late-stage human healthcare and biotechnology companies with special focus on pharmaceuticals, diagnostics and medical devices. Ysios launched its first 69 million Euro fund Ysios BioFund I in 2008. Ysios has invested in 10 companies, and has successfully exited from BioVex (sold to Amgen for up to 1 billion USD) and from Endosense (sold to St. Jude Medical for up to 325 million CHF), and floated adult stem cell therapy company Cellerix on the NYSE Euronext Brussels through a reverse merger with Tigenix. The current active portfolio of Ysios BioFund I includes AM-Pharma (The Netherlands), Cardoz (Sweden), CVRx (United States), Inbiomotion (Spain), Medlumics (Spain), STAT-Diagnostica (Spain) and TIG:BB Tigenix (Belgium). *

 



Period Start 2008-01-01 established
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Person Person Jean-Mairet, Joël (Ysios Capital 201206)
     
Region Region Barcelona
  Country Spain (España)
  Street 11 Travessera de Gràcia
8th Floor
  City 08021 Barcelona
  Tel +34-93-517-3545
    Address record changed: 2015-08-20
     
Basic data Employees B: 11 to 50
  Currency EUR
  Annual sales 125,000,000 (assets, managed (2015) 2015-08-18)
     
    * Document for �About Section�: Ysios Capital. (3/19/14). "Press Release: Ysios Capital Begins Fundraising for Ysios Biofund II. New Fund to Back Disruptive Life Sciences Company in Europe and US". Barcelona.
     
   
Record changed: 2019-06-28

Advertisement

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Ysios Capital (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px




» top